207 related articles for article (PubMed ID: 22314185)
21. Value of D2-40 in the differential diagnosis of pleural neoplasms with emphasis on its positivity in solitary fibrous tumor.
Hu Y; Yang Q; McMahon LA; Wang HL; Xu H
Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):411-3. PubMed ID: 20436345
[TBL] [Abstract][Full Text] [Related]
22. Expression of FKBP12 in benign and malignant vascular endothelium: an immunohistochemical study on conventional sections and tissue microarrays.
Higgins JP; Montgomery K; Wang L; Domanay E; Warnke RA; Brooks JD; van de Rijn M
Am J Surg Pathol; 2003 Jan; 27(1):58-64. PubMed ID: 12502928
[TBL] [Abstract][Full Text] [Related]
23. CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: report of 145 cases and review of putative immunohistologic markers of endothelial differentiation.
DeYoung BR; Swanson PE; Argenyi ZB; Ritter JH; Fitzgibbon JF; Stahl DJ; Hoover W; Wick MR
J Cutan Pathol; 1995 Jun; 22(3):215-22. PubMed ID: 7593814
[TBL] [Abstract][Full Text] [Related]
24. D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma.
Ordóñez NG
Hum Pathol; 2005 Apr; 36(4):372-80. PubMed ID: 15891998
[TBL] [Abstract][Full Text] [Related]
25. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors.
Xu H; Edwards JR; Espinosa O; Banerji S; Jackson DG; Athanasou NA
Hum Pathol; 2004 Jul; 35(7):857-61. PubMed ID: 15257549
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas.
Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U
J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962
[TBL] [Abstract][Full Text] [Related]
27. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
Miettinen M; Lindenmayer AE; Chaubal A
Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718
[TBL] [Abstract][Full Text] [Related]
28. Papillary intralymphatic angioendothelioma (PILA): a report of twelve cases of a distinctive vascular tumor with phenotypic features of lymphatic vessels.
Fanburg-Smith JC; Michal M; Partanen TA; Alitalo K; Miettinen M
Am J Surg Pathol; 1999 Sep; 23(9):1004-10. PubMed ID: 10478659
[TBL] [Abstract][Full Text] [Related]
29. Differential Prox-1 and CD 31 expression in mucousae, cutaneous and soft tissue vascular lesions and tumors.
Reis RM; Reis-Filho JS; Longatto Filho A; Tomarev S; Silva P; Lopes JM
Pathol Res Pract; 2005; 201(12):771-6. PubMed ID: 16308102
[TBL] [Abstract][Full Text] [Related]
30. VEGFR2 regulates endothelial differentiation of colon cancer cells.
Liu Z; Qi L; Li Y; Zhao X; Sun B
BMC Cancer; 2017 Aug; 17(1):593. PubMed ID: 28854900
[TBL] [Abstract][Full Text] [Related]
31. Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.
Capkova L; Koubkova L; Kodet R
Neoplasma; 2014; 61(2):161-9. PubMed ID: 24471939
[TBL] [Abstract][Full Text] [Related]
32. Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 or FLT1.
Soini Y; Puhakka A; Kahlos K; Säily M; Pääkkö P; Koistinen P; Kinnula V
Histopathology; 2001 Aug; 39(2):179-86. PubMed ID: 11493335
[TBL] [Abstract][Full Text] [Related]
33. FOSB is a Useful Diagnostic Marker for Pseudomyogenic Hemangioendothelioma.
Hung YP; Fletcher CD; Hornick JL
Am J Surg Pathol; 2017 May; 41(5):596-606. PubMed ID: 28009608
[TBL] [Abstract][Full Text] [Related]
34. Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas.
Miettinen M; Limon J; Niezabitowski A; Lasota J
Virchows Arch; 2000 Sep; 437(3):275-83. PubMed ID: 11037348
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
36. Identification of a high molecular weight endothelial cell surface glycoprotein, endoGlyx-1, in normal and tumor blood vessels.
Sanz-Moncasi MP; Garin-Chesa P; Stockert E; Jaffe EA; Old LJ; Rettig WJ
Lab Invest; 1994 Sep; 71(3):366-73. PubMed ID: 7933987
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine-1-phosphate receptor 1 is a useful adjunct for distinguishing vascular neoplasms from morphological mimics.
Akiyama T; Hamazaki S; Monobe Y; Nishimura H; Irei I; Sadahira Y
Virchows Arch; 2009 Feb; 454(2):217-22. PubMed ID: 19005676
[TBL] [Abstract][Full Text] [Related]
38. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia.
Traweek ST; Kandalaft PL; Mehta P; Battifora H
Am J Clin Pathol; 1991 Jul; 96(1):25-31. PubMed ID: 1712541
[TBL] [Abstract][Full Text] [Related]
39. Expression of thrombomodulin, calretinin, cytokeratin 5/6, D2-40 and WT-1 in a series of primary carcinomas of the lung: an immunohistochemical study in comparison with epithelioid pleural mesothelioma.
Comin CE; Novelli L; Cavazza A; Rotellini M; Cianchi F; Messerini L
Tumori; 2014; 100(5):559-67. PubMed ID: 25343553
[TBL] [Abstract][Full Text] [Related]
40. CD30 expression in malignant vascular tumors and its diagnostic and clinical implications: a study of 146 cases.
Alimchandani M; Wang ZF; Miettinen M
Appl Immunohistochem Mol Morphol; 2014; 22(5):358-62. PubMed ID: 24805132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]